ESC 365 - Doctor Francesco Melillo

Speaker illustration

Doctor Francesco Melillo

IRCCS San Raffaele Scientific Institute, Milan (Italy)

Member of:

Impact on outcome of different etiologies, baseline degree and improvement of mitral regurgitation in patients with aortic stenosis who underwent transcatheter aortic valve replacement

Event: EACVI - Best of Imaging 2020

Topic: Valvular Heart Disease

Session: Live Abstract Presentations - Valvular Heart Diseases

Two-years outcome of patients with heart failure and severe left ventricular dysfunction treated with ivabradine and low doses of beta-blocker

Event: Heart Failure 2018

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

One-year clinical outcome and predictors of adverse events after percutaneous coronary intervention in elderly patients

Event: ESC Congress 2017

Topic: CAD and comorbidities

Session: CAD and comorbidities

Real-world single tertiary-care multidisciplinary experience with dabigatran, apixaban, rivaroxaban and warfarin in patients with renal failure and concomitant NVAF.

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Stroke prevention

Clinical outcome of low-dose regimen of dabigatran, apixaban, rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation: a single tertiary care multidisciplinary experience.

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Stroke prevention

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources